Several attorneys from Williams Kherkher will be volunteering their time and efforts this Wednesday, September 2nd, at the Houston Bar Association’s LegalLine.
Twice a month, the Houston Bar Association (HBA) holds their LegalLine program, offering individuals from around Harris County an opportunity to call in and receive free legal advice from licensed attorneys between the hours of 5:00 and 9:00 pm. This important event takes place on the first and third Wednesdays of every month, and the team at Williams Kherkher is happy to have the chance to regularly volunteer for such an important program.
Twelve lawmakers have asked a government watchdog agency to inquire further as to why the U.S. Food and Drug Administration (FDA) took a long time to warn about power morcellators‘ risk of spreading undetected uterine cancer, Medscape reported on Tuesday, August 11.
In a letter addressed to the U.S. Government Accountability Office (GAO), the members of Congress requested a study about the FDA’s delayed response over the medical device’s cancer risk. Lawmakers also asked the GAO to investigate whether the FDA’s current process of approving medical devices was enough to detect the dangers posed by the device.
In April 2014, the FDA advised surgeons to stop using power morcellators for uterine fibroid removal after learning that 1 in 350 women with benign uterine masses have undetected uterine cancer.
If your health has been compromised after undergoing a laparoscopic procedure involving a power morcellator, our team of power morcellator attorneys at Williams Kherkher might be able to help you secure the compensation you believe you deserve from the device manufacturer involved. Call us at (800) 220-9341 and tell us more about your situation.
Liquid Transfer Terminals in Bainbridge, Georgia was the site of an explosion on Wednesday morning, August 19, resulting in a fire and massive amounts of black smoke pouring from the plant. Roads around the area were closed until as late as 5 p.m. due to the potential exposure to hazardous chemicals. Neighborhoods close to the plant were evacuated and schools in the area were on lockdown to protect children from exposure.
The explosion reportedly killed one man while he was welding at the top of the plant. The explosion is suspected to have been initiated due to a spark from this welding. Another worker was on his way to relieve the welder from his position when the explosion occurred. The second worker is reportedly uninjured.
The fire was extinguished by 2:30 p.m. on the same day, however, officials kept a diligent watch on the area as smoke continued to flow from the plant as chemicals burned down.
The first of a series of explosions at the DrillChem chemical plant in Conroe, TX, just north of Houston, occurred at 4:40 pm on Friday, August 14th. These explosions resulted in a massive 3-alarm fire at the plant, with safety officials closing nearby roadways and issuing a shelter in place ordinance for those living within a 2-mile radius of the plant.
A hazmat team from The Woodlands, as well as more than 50 firefighters, responded to the blaze and began fighting the fire at around 6 pm, with the fire coming under control around 6:15 pm. Loop 336 was re-opened by 8:30 pm, and the shelter request was lifted last night.
Authorities worried that there could have been individuals inside or near the plant at the time of the explosion. However, representatives of the company state that the last employee left for the day at 4pm.
Patients whose endometrial cancer has been diagnosed and treated early on have a better chance of survival and cure. In fact, diagnosing and treating earlier stages of endometrial cancer (stage 0 to stage 2) provide a 5-year survival rate of 69% to 90%. So, at the early stages at least, there are a majority of good outcomes for endometrial cancer patients.
One of the most effective treatment options for endometrial cancer is chemotherapy. Chemotherapy involves the use of a combination of drugs to fight against cancer. Because these cancer-fighting drugs reach throughout the body, chemotherapy is an effective treatment for endometrial cancer that has already spread beyond the uterus and the pelvic area.
Hysterectomies utilizing power morcellators have been found to increase the risk of spreading undetected uterine cancer. If you have been harmed by this device, you might be eligible to file a claim against the manufacturer of this product. To learn more about seeking compensation, consult with our power morcellator legal team at Williams Kherkher by calling (888) 220-0640 today.
Uterine cancer is considered among the deadliest types of cancer affecting women. In fact, the American Cancer Society predicts that this year, about 10,170 women will die from uterine cancer complications. The agency also said approximately 54,870 women will be diagnosed with the disease.
One of the most common endometrial cancer treatments is radiation therapy. Radiation therapy involves the use of radiation to kill cancer cells and can be performed using a machine outside the body (external beam radiation), or a radiation-filled device placed inside the body (brachytherapy). However, people undergoing radiation therapy for uterine cancer may experience some side-effects, such as rectal bleeding, bladder irritation, incontinence, and sexual problems.
Some studies showed that the risk of uterine cancer is higher among women who have undergone laparoscopic procedure involving a power morcellator. If this device has caused you harm, you might be eligible to seek compensation from the manufacturer involved. Speak with our team at Williams Kherkher by calling (888) 220-0640 today to learn more about filing a lawsuit.
Until 2006, the U.S. Food and Drug Administration (FDA) did not allow Janssen Pharmaceutical to market its atypical anti-psychotic drug Risperdal for use in children due to lack of evidence that the drug is safe for pediatric use. However, a 1994 product outline revealed that the company planned to promote the drug for off-label use in children, causing the company to be involved in many lawsuits.
The use of a drug for conditions other than what it is approved for can be risky. Because doctors have no duty to disclose to their patients whether they are receiving an off label prescription or not, you should ask your doctor right away if you are receiving drugs off label. If so, ask them about how sure they are about prescribing you the drug, and how certain they are that you will benefit from it.
Some drug companies engage in unfair practices, such as selling their products for unapproved uses at consumers’ expense. If you think Risperdal has harmed you or your loved one, speak with an attorney at Williams Kherkher by calling (888) 220-0640 to learn more about taking legal action against the pharmaceutical company involved.
Earlier this month, lawyers of plaintiffs who sued J&J over its power morcellator filed a request to consolidate similar suits in Multidistrict Litigation (MDL). MDL is a legal procedure that combines comparable lawsuits filed by different parties. This is different from class action, which involves a single lawsuit collectively filed by representatives of a larger group of complainants.
Both MDL and class action suits are used by the U.S. courts to manage mass torts. These tools make pre-trial procedures, including the discovery of evidence, more consolidated, convenient, and expeditious. However, because a class action involves only one lawsuit, all class member claimants are bounded by the same settlement and would receive substantially identical compensations. On the other hand, because MDLs are considered separate cases, claimants can be awarded recovery amounts based on the damages they individually claimed.
If you have been harmed by a power morcellator, our team of product liability attorneys at Williams Kherkher may help you file a claim against the manufacturer involved. Call us at (888) 220-0640 today to learn more.
Researchers at the University of Melbourne found that women with Lynch syndrome have a lower risk of uterine cancer if they are taking hormonal contraceptives or have been pregnant before, Health Canal reported on July 7.
The study, which involved 1,128 women with a gene mutation that causes Lynch syndrome, found that women who had one child were 60% less likely to have uterine cancer compared to those who had none. The risk became even lower for women with more than one child. On the other hand, women who took hormonal contraceptives for at least a year decreased their risk of uterine cancer by 50%.
Lynch syndrome is a genetic disease that increases a woman’s risk of certain types of cancer, including uterine cancer. One in 1,000 women has a Lynch syndrome-causing gene mutation.
Apart from Lynch syndrome, the use of a power morcellator during hysterectomies also increases a woman’s risk of uterine cancer. Speak with an attorney at Williams Kherkher by calling (888) 220-0640 to learn more about how to hold the maker of this dangerous medical device accountable for the harm it has caused you.
Scoliosis, or the abnormal curvature of the spine, affects 2% to 3% of the U.S. population, or approximately 6 to 9 people in the country. Although the onset of scoliosis usually appears between ages 10 and 15, some develop this disease during infancy or early childhood. When signs and symptoms of scoliosis appear between birth and 3 years of age, it is called infantile scoliosis.
Your baby might be suffering from scoliosis if:
- A bulge appears on one side of the chest
- The baby consistently lies curved on one side
- The baby is suffering from conditions affecting the lungs or the heart
- The baby is difficult to feed because of shortness of breath
- The baby is restless or irritated because of chest pain
Several studies have shown links between infantile scoliosis and the migraine drug Depakote taken during pregnancy. If you believe your child’s scoliosis has resulted from taking this drug, our team of defective pharmaceutical attorneys at Williams Kherkher is here to help assess your situation. Call us at (888) 220-0640 to learn if your circumstances qualify you to file a claim against the manufacturer involved.
« Previous 1 … 9 10 11 12 13 … 40 Next »